Search

 
 
 
 
 
 
After a Clinical Trial Death, FDA OKs New Tests of Akashi's Duchenne Drug

AFTER A CLINICAL TRIAL DEATH, FDA OKS NEW TESTS OF AKASHI'S DUCHENNE DRUG

Akashi Therapeutics has been cleared by the FDA to resume testing an experimental Duchenne muscular dystrophy drug roughly a year after...

FDA approves Duchenne muscular dystrophy drug

FDA APPROVES DUCHENNE MUSCULAR DYSTROPHY DRUG

The FDA has given the green light to Emflaza , a new drug for Duchenne muscular dystrophy. Announced Thursday, the news is bittersweet....